Home › Companies › CATALYST PHARMACEUTICALS INC. › 2023-2024

CATALYST PHARMACEUTICALS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and CATALYST PHARMACEUTICALS INC.’s Form 8-K, filed 2024-05-21 (Item 5.07 on EDGAR). Page generated 02 October 2026.

43Reported items
333Asset managers
7,406Fund votes
2024-05-21Main meeting date

Proxy season: 2023-2024 2024-2025

Explore CATALYST PHARMACEUTICALS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by CATALYST PHARMACEUTICALS INC.

These tallies are CATALYST PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-21 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CATALYST PHARMACEUTICALS INC. — official shareholder meeting results, meeting held 2024-05-21
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Richard J. Daly	88,161,224	1,489,928	193,687	--	11,817,471	Majority: yes
Elect Director: Patrick J. McEnany	86,093,354	3,561,412	190,073	--	11,817,471	Majority: yes
Elect Director: Donald A. Denkhaus	85,937,799	3,717,631	189,409	--	11,817,471	Majority: yes
Elect Director: Molly Harper	86,018,457	3,637,844	188,538	--	11,817,471	Majority: yes
Elect Director: Charles B. O'Keeffe	84,926,089	4,730,350	188,400	--	11,817,471	Majority: yes
Elect Director: Tamar Thompson	85,049,382	4,604,945	190,512	--	11,817,471	Majority: yes
Elect Director: David S. Tierney	85,767,244	3,885,606	191,989	--	11,817,471	Majority: yes
Proposal 2: Approval of an amendment to our 2018 Stock Incentive Plan:	86,817,240	2,859,403	168,196	--	11,817,471	Majority: yes
Proposal 3: Approval, on an advisory basis, of the 2023 compensation of our named executive officers:	84,194,484	5,468,681	181,674	--	11,817,471	Majority: yes
Proposal 4: Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024:	99,551,894	2,031,301	79,115	--	--	Majority: yes

Source: CATALYST PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-05-21 — read the filing on EDGAR.

How asset managers voted at the CATALYST PHARMACEUTICALS INC. 2023-2024 meetings

Each item below shows how the 333 asset managers that disclosed a CATALYST PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CATALYST PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the 2023 compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 7 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 84,194,484AGAINST: 5,468,681

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Approval, on an advisory basis, of the 2023 compensation of our named executive officers:”): 84,194,484 for, 5,468,681 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 71% for, 5% against (76% of the company cast a for/against vote).

The 294 asset managers below cast 91% of the shares they voted on this item FOR (79,286,040 for, 7,561,948 against).

FOR 91%9%

FOR: 79,286,040 (90.8%)AGAINST: 7,561,948 (8.7%)ABSTAIN: 23,783 (0.0%)UNKNOWN: 413,392 (0.5%)NOT VOTED: 14 (0.0%)

Largest asset managers voting on “To approve, on an advisory basis, the 2023 compensation of our named executive officers.” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	15,816,773	15,065	For
State Street	13,838,278	3,811	For
Vanguard	7,975,077	0	For
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	4,045,754	0	For
Fidelity	2,677,994	0	For
Dimensional	2,587,625	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,507,305	0	For
Man Group plc	0	2,485,040	Against
T. Rowe Price	2,109,187	0	For
Charles Schwab	2,091,220	0	For
Invesco	1,801,772	0	For
Royce	1,605,201	0	For
MARSHALL WACE, LLP	0	1,457,090	Against
Northern Trust	1,442,890	0	For
American Century	0	1,195,719	Against
JACOBS LEVY EQUITY MANAGEMENT, INC	1,046,858	0	For
Opaleye Management Inc.	0	1,035,000	Against
KENNEDY CAPITAL MANAGEMENT LLC	942,872	5,929	For
MELLON INVESTMENTS Corp	878,860	0	For
JANUS INVESTMENT FUND	672,701	0	For
PNC BANK, NATIONAL ASSOCIATION	669,983	54	For
JPMorgan	648,990	0	For
PRINCIPAL GLOBAL INVESTORS	647,298	0	For
Mesirow Institutional Investment Management, Inc.	619,620	0	For
Renaissance	525,697	0	For

Showing the 25 largest of 294 asset managers. See all 294 in the interactive database.

2. PROPOSAL THREE - To approve, on an advisory basis, the 2022 compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 5 wordings of this item as funds reported it.

95% fund support · no official result

FOR 95%

The 151 asset managers below cast 95% of the shares they voted on this item FOR (59,959,755 for, 3,007,398 against).

FOR: 59,959,755 (95.2%)AGAINST: 3,007,398 (4.8%)

Largest asset managers voting on “PROPOSAL THREE - To approve, on an advisory basis, the 2022 compensation of our named executive officers.” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
State Street	16,612,671	0	For
BlackRock	11,960,464	1,374	For
Vanguard	6,871,824	0	For
Dimensional	2,340,389	0	For
Invesco	0	2,252,015	Against
Fidelity	2,023,653	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,926,415	0	For
T. Rowe Price	1,902,000	0	For
American Century	1,491,562	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	1,016,746	0	For
Maryland State Retirement & Pension System	1,000,000	0	For
MELLON INVESTMENTS Corp	811,990	0	For
Royce	803,783	0	For
Allspring	609,962	0	For
PRINCIPAL GLOBAL INVESTORS	580,990	0	For
Voya	534,737	0	For
AllianceBernstein	478,690	0	For
Goldman Sachs	453,696	0	For
Victory Capital	441,615	0	For
Direxion Shares ETF Trust	435,872	0	For
Rafferty Asset Management, LLC	435,872	0	For
BNY Mellon	428,318	0	For
Northern Trust	368,585	0	For
Columbia Threadneedle	0	356,094	Against
KENNEDY CAPITAL MANAGEMENT LLC	281,998	0	For

Showing the 25 largest of 151 asset managers. See all 151 in the interactive database.

3. To approve, on an advisory basis, the 2022 compensation of our named executive officers

COMPENSATION

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 4 wordings of this item as funds reported it.

99.3% fund support · no official result

FOR 96%

The 114 asset managers below cast 99.3% of the shares they voted on this item FOR (17,385,895 for, 112,834 against).

FOR: 17,385,895 (96.1%)AGAINST: 112,834 (0.6%)ABSTAIN: 23,783 (0.1%)UNKNOWN: 563,392 (3.1%)

Largest asset managers voting on “To approve, on an advisory basis, the 2022 compensation of our named executive officers” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	8,192,000	0	For
Charles Schwab	1,721,383	0	For
Man Group plc	1,313,460	0	For
Prudential/PGIM	822,628	9,300	For
PNC BANK, NATIONAL ASSOCIATION	584,312	0	For
JW Asset Management, LLC	0	0	Unknown
J. Goldman & Co LP	524,816	0	For
JPMorgan	433,651	0	For
SEI	405,829	0	For
Putnam	310,539	0	For
LSV ASSET MANAGEMENT	291,401	5,100	For
Jackson National	263,946	0	For
Northern Trust	227,772	0	For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	193,053	0	For
MOODY ALDRICH PARTNERS LLC	187,719	0	For
Federated Hermes	187,520	0	For
MARSHALL WACE, LLP	173,199	0	For
Russell Investments	157,634	0	For
World Funds Trust	154,809	0	For
Clark Capital Management Group, Inc.	115,171	0	For
CAPITAL FUND MANAGEMENT S.A.	90,374	0	For
BANK OF AMERICA NA	77,081	0	For
ADVISORS' INNER CIRCLE FUND	74,900	0	For
EntrepreneurShares Series Trust	73,805	0	For
Allianz	71,107	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

4. Election of Directors To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 84,926,089AGAINST: 4,730,350

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Charles B. O'Keeffe”): 84,926,089 for, 4,730,350 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 72% for, 4% against (76% of the company cast a for/against vote).

The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (43,568,853 for, 37,502 against).

FOR 99.8%

FOR: 43,568,853 (99.9%)AGAINST: 37,502 (0.1%)ABSTAIN: 23,783 (0.1%)

Largest asset managers voting on “Election of Directors To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2025 Annual” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	12,056,213	0	For
Vanguard	7,681,821	0	For
State Street	5,914,658	2,335	For
Fidelity	2,606,331	0	For
Dimensional	2,312,134	0	For
Royce	1,467,476	0	For
Charles Schwab	1,016,458	0	For
T. Rowe Price	911,552	0	For
Invesco	865,133	0	For
JANUS INVESTMENT FUND	672,701	0	For
American Century	597,439	0	For
Altium Capital Management LP	500,000	0	For
OBERWEIS FUNDS	458,400	0	For
TIAA	426,573	0	For
Janus Detroit Street Trust	330,359	0	For
Direxion Shares ETF Trust	311,886	0	For
Columbia Threadneedle	306,731	0	For
Northern Trust	297,820	0	For
RBB FUND, INC.	290,561	0	For
JPMorgan	285,125	0	For
Equitable	276,446	0	For
Jackson National	267,975	0	For
First Trust	223,487	0	For
QUANTITATIVE MASTER SERIES LLC	195,270	0	For
BNY Mellon	178,485	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

5. Election of Directors To elect Donald A. Denkhaus as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 85,937,799AGAINST: 3,717,631

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Donald A. Denkhaus”): 85,937,799 for, 3,717,631 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 73% for, 3% against (76% of the company cast a for/against vote).

The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (43,570,823 for, 35,532 against).

FOR 99.8%

FOR: 43,570,823 (99.9%)AGAINST: 35,532 (0.1%)ABSTAIN: 23,783 (0.1%)

Largest asset managers voting on “Election of Directors To elect Donald A. Denkhaus as a member of the Board of Directors until the 2025 Annual ” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	12,056,213	0	For
Vanguard	7,681,821	0	For
State Street	5,915,456	1,537	For
Fidelity	2,606,331	0	For
Dimensional	2,312,134	0	For
Royce	1,467,476	0	For
Charles Schwab	1,016,458	0	For
T. Rowe Price	911,552	0	For
Invesco	865,133	0	For
JANUS INVESTMENT FUND	672,701	0	For
American Century	597,439	0	For
Altium Capital Management LP	500,000	0	For
OBERWEIS FUNDS	458,400	0	For
TIAA	426,573	0	For
Janus Detroit Street Trust	330,359	0	For
Direxion Shares ETF Trust	311,886	0	For
Columbia Threadneedle	306,731	0	For
Northern Trust	297,820	0	For
RBB FUND, INC.	290,561	0	For
JPMorgan	285,125	0	For
Equitable	276,446	0	For
Jackson National	267,975	0	For
First Trust	223,487	0	For
QUANTITATIVE MASTER SERIES LLC	195,270	0	For
BNY Mellon	178,485	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

6. Election of Directors To elect Molly Harper as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until her earlier death, disability or resignation:

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 86,018,457AGAINST: 3,637,844

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Molly Harper”): 86,018,457 for, 3,637,844 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 73% for, 3% against (76% of the company cast a for/against vote).

The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (43,570,823 for, 35,532 against).

FOR 99.8%

FOR: 43,570,823 (99.9%)AGAINST: 35,532 (0.1%)ABSTAIN: 23,783 (0.1%)

Largest asset managers voting on “Election of Directors To elect Molly Harper as a member of the Board of Directors until the 2025 Annual Meetin” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	12,056,213	0	For
Vanguard	7,681,821	0	For
State Street	5,915,456	1,537	For
Fidelity	2,606,331	0	For
Dimensional	2,312,134	0	For
Royce	1,467,476	0	For
Charles Schwab	1,016,458	0	For
T. Rowe Price	911,552	0	For
Invesco	865,133	0	For
JANUS INVESTMENT FUND	672,701	0	For
American Century	597,439	0	For
Altium Capital Management LP	500,000	0	For
OBERWEIS FUNDS	458,400	0	For
TIAA	426,573	0	For
Janus Detroit Street Trust	330,359	0	For
Direxion Shares ETF Trust	311,886	0	For
Columbia Threadneedle	306,731	0	For
Northern Trust	297,820	0	For
RBB FUND, INC.	290,561	0	For
JPMorgan	285,125	0	For
Equitable	276,446	0	For
Jackson National	267,975	0	For
First Trust	223,487	0	For
QUANTITATIVE MASTER SERIES LLC	195,270	0	For
BNY Mellon	178,485	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

7. Election of Directors To elect Patrick J. McEnany as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 6 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 86,093,354AGAINST: 3,561,412

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Patrick J. McEnany”): 86,093,354 for, 3,561,412 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 73% for, 3% against (76% of the company cast a for/against vote).

The 95 asset managers below cast 99.7% of the shares they voted on this item FOR (43,485,137 for, 111,294 against).

FOR 99.6%

FOR: 43,485,137 (99.7%)AGAINST: 111,294 (0.3%)ABSTAIN: 23,783 (0.1%)

Largest asset managers voting on “Election of Directors To elect Patrick J. McEnany as a member of the Board of Directors until the 2025 Annual ” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	12,056,213	0	For
Vanguard	7,681,821	0	For
State Street	5,915,407	1,586	For
Fidelity	2,606,331	0	For
Dimensional	2,312,134	0	For
Royce	1,467,476	0	For
Charles Schwab	1,016,458	0	For
T. Rowe Price	911,552	0	For
Invesco	865,133	0	For
JANUS INVESTMENT FUND	672,701	0	For
American Century	597,439	0	For
Altium Capital Management LP	500,000	0	For
OBERWEIS FUNDS	458,400	0	For
TIAA	426,573	0	For
Janus Detroit Street Trust	330,359	0	For
Direxion Shares ETF Trust	311,886	0	For
Columbia Threadneedle	306,731	0	For
Northern Trust	297,820	0	For
RBB FUND, INC.	290,561	0	For
JPMorgan	285,125	0	For
Equitable	276,446	0	For
Jackson National	267,975	0	For
First Trust	223,487	0	For
QUANTITATIVE MASTER SERIES LLC	195,270	0	For
BNY Mellon	178,485	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

8. Election of Directors To elect Richard J. Daly as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 88,161,224AGAINST: 1,489,928

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Richard J. Daly”): 88,161,224 for, 1,489,928 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 75% for, 1% against (76% of the company cast a for/against vote).

The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (43,583,219 for, 23,136 against).

FOR 99.8%

FOR: 43,583,219 (99.9%)AGAINST: 23,136 (0.1%)ABSTAIN: 23,783 (0.1%)

Largest asset managers voting on “Election of Directors To elect Richard J. Daly as a member of the Board of Directors until the 2025 Annual Mee” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	12,056,213	0	For
Vanguard	7,681,821	0	For
State Street	5,915,407	1,586	For
Fidelity	2,606,331	0	For
Dimensional	2,312,134	0	For
Royce	1,467,476	0	For
Charles Schwab	1,016,458	0	For
T. Rowe Price	911,552	0	For
Invesco	865,133	0	For
JANUS INVESTMENT FUND	672,701	0	For
American Century	597,439	0	For
Altium Capital Management LP	500,000	0	For
OBERWEIS FUNDS	458,400	0	For
TIAA	426,573	0	For
Janus Detroit Street Trust	330,359	0	For
Direxion Shares ETF Trust	311,886	0	For
Columbia Threadneedle	306,731	0	For
Northern Trust	297,820	0	For
RBB FUND, INC.	290,561	0	For
JPMorgan	285,125	0	For
Equitable	276,446	0	For
Jackson National	267,975	0	For
First Trust	223,487	0	For
QUANTITATIVE MASTER SERIES LLC	195,270	0	For
BNY Mellon	178,485	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

9. Election of Directors To elect Tamar Thompson as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until her earlier death, disability or resignation:

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 85,049,382AGAINST: 4,604,945

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Tamar Thompson”): 85,049,382 for, 4,604,945 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 72% for, 4% against (76% of the company cast a for/against vote).

The 95 asset managers below cast 99.3% of the shares they voted on this item FOR (43,322,139 for, 284,216 against).

FOR 99.2%

FOR: 43,322,139 (99.3%)AGAINST: 284,216 (0.7%)ABSTAIN: 23,783 (0.1%)

Largest asset managers voting on “Election of Directors To elect Tamar Thompson as a member of the Board of Directors until the 2025 Annual Meet” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	12,056,213	0	For
Vanguard	7,681,821	0	For
State Street	5,915,456	1,537	For
Fidelity	2,606,331	0	For
Dimensional	2,312,134	0	For
Royce	1,467,476	0	For
Charles Schwab	1,016,458	0	For
T. Rowe Price	911,552	0	For
Invesco	865,133	0	For
JANUS INVESTMENT FUND	672,701	0	For
American Century	597,439	0	For
Altium Capital Management LP	500,000	0	For
OBERWEIS FUNDS	458,400	0	For
TIAA	426,573	0	For
Janus Detroit Street Trust	330,359	0	For
Direxion Shares ETF Trust	311,886	0	For
Columbia Threadneedle	306,731	0	For
Northern Trust	297,820	0	For
RBB FUND, INC.	290,561	0	For
JPMorgan	285,125	0	For
Equitable	276,446	0	For
Jackson National	267,975	0	For
First Trust	223,487	0	For
QUANTITATIVE MASTER SERIES LLC	195,270	0	For
BNY Mellon	178,485	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

10. Election of Directors To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2025 Annual Meeting of Stockholders, or until his earlier death, disability or resignation:

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 85,767,244AGAINST: 3,885,606

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David S. Tierney”): 85,767,244 for, 3,885,606 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 73% for, 3% against (76% of the company cast a for/against vote).

The 94 asset managers below cast 99.9% of the shares they voted on this item FOR (43,471,943 for, 37,502 against).

FOR 99.8%

FOR: 43,471,943 (99.9%)AGAINST: 37,502 (0.1%)ABSTAIN: 23,783 (0.1%)

Largest asset managers voting on “Election of Directors To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2025 Ann” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	12,056,213	0	For
Vanguard	7,681,821	0	For
State Street	5,914,658	2,335	For
Fidelity	2,606,331	0	For
Dimensional	2,312,134	0	For
Royce	1,467,476	0	For
Charles Schwab	1,016,458	0	For
T. Rowe Price	911,552	0	For
Invesco	865,133	0	For
JANUS INVESTMENT FUND	672,701	0	For
American Century	597,439	0	For
Altium Capital Management LP	500,000	0	For
OBERWEIS FUNDS	458,400	0	For
TIAA	426,573	0	For
Janus Detroit Street Trust	330,359	0	For
Direxion Shares ETF Trust	311,886	0	For
Columbia Threadneedle	306,731	0	For
Northern Trust	297,820	0	For
RBB FUND, INC.	290,561	0	For
JPMorgan	285,125	0	For
Equitable	276,446	0	For
Jackson National	267,975	0	For
First Trust	223,487	0	For
QUANTITATIVE MASTER SERIES LLC	195,270	0	For
BNY Mellon	178,485	0	For

Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.

11. To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 99,551,894AGAINST: 2,031,301

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Ratification of the selection of Grant Thornton, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024:”): 99,551,894 for, 2,031,301 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 84% for, 2% against (86% of the company cast a for/against vote).

The 93 asset managers below cast 99.9% of the shares they voted on this item FOR (43,456,279 for, 799 against).

FOR 99.9%

FOR: 43,456,279 (100.0%)AGAINST: 799 (0.0%)

Largest asset managers voting on “To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fis” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	12,056,213	0	For
Vanguard	7,681,821	0	For
State Street	5,916,194	799	For
Fidelity	2,606,331	0	For
Dimensional	2,312,134	0	For
Royce	1,467,476	0	For
Charles Schwab	1,016,458	0	For
T. Rowe Price	911,552	0	For
Invesco	865,133	0	For
JANUS INVESTMENT FUND	672,701	0	For
American Century	597,439	0	For
Altium Capital Management LP	500,000	0	For
OBERWEIS FUNDS	458,400	0	For
TIAA	426,573	0	For
Janus Detroit Street Trust	330,359	0	For
Direxion Shares ETF Trust	311,886	0	For
Columbia Threadneedle	306,731	0	For
Northern Trust	297,820	0	For
RBB FUND, INC.	290,561	0	For
JPMorgan	285,125	0	For
Equitable	276,446	0	For
Jackson National	243,246	0	For
First Trust	223,487	0	For
QUANTITATIVE MASTER SERIES LLC	195,270	0	For
BNY Mellon	178,485	0	For

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

12. To transact such other business as may properly come before the meeting.

OTHER

Meeting held 2024-05-21.

Combines 2 wordings of this item as funds reported it.

2% fund support · no official result

AGAINST 98%

The 93 asset managers below cast 2% of the shares they voted on this item FOR (805,805 for, 42,602,842 against).

FOR: 805,805 (1.9%)AGAINST: 42,602,842 (98.1%)

Largest asset managers voting on “To transact such other business as may properly come before the meeting.” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	0	12,056,213	Against
Vanguard	0	7,681,821	Against
State Street	5,393	5,911,600	Against
Fidelity	0	2,606,331	Against
Dimensional	0	2,312,134	Against
Royce	0	1,467,476	Against
Charles Schwab	0	1,016,458	Against
T. Rowe Price	0	911,552	Against
Invesco	0	865,133	Against
JANUS INVESTMENT FUND	0	672,701	Against
American Century	0	597,439	Against
Altium Capital Management LP	500,000	0	For
OBERWEIS FUNDS	0	458,400	Against
TIAA	0	426,573	Against
Janus Detroit Street Trust	0	330,359	Against
Direxion Shares ETF Trust	0	311,886	Against
Columbia Threadneedle	0	306,731	Against
Northern Trust	0	297,820	Against
RBB FUND, INC.	0	290,561	Against
JPMorgan	285,125	0	For
Equitable	0	276,446	Against
Jackson National	0	267,975	Against
First Trust	0	223,487	Against
QUANTITATIVE MASTER SERIES LLC	0	195,270	Against
BNY Mellon	0	178,485	Against

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

13. Election of Directors To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares.

COMPENSATION

Meeting held 2024-05-21.

98% fund support · no official result

FOR 98%

The 66 asset managers below cast 98% of the shares they voted on this item FOR (39,700,114 for, 615,644 against).

FOR: 39,700,114 (98.5%)AGAINST: 615,644 (1.5%)

Largest asset managers voting on “Election of Directors To approve an amendment to our 2018 Stock Incentive Plan to increase the shares availabl” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	12,056,213	0	For
Vanguard	7,681,821	0	For
State Street	5,916,194	799	For
Fidelity	2,606,331	0	For
Dimensional	2,312,134	0	For
Royce	1,467,476	0	For
T. Rowe Price	911,552	0	For
Invesco	865,133	0	For
JANUS INVESTMENT FUND	672,701	0	For
American Century	0	597,439	Against
OBERWEIS FUNDS	458,400	0	For
TIAA	426,573	0	For
Janus Detroit Street Trust	330,359	0	For
Direxion Shares ETF Trust	311,886	0	For
Columbia Threadneedle	306,731	0	For
Northern Trust	297,820	0	For
Equitable	276,446	0	For
First Trust	223,487	0	For
RBB FUND, INC.	204,965	0	For
QUANTITATIVE MASTER SERIES LLC	195,270	0	For
BNY Mellon	178,485	0	For
FRANKLIN VALUE INVESTORS TRUST	169,495	0	For
Goldman Sachs	141,147	0	For
Principal	127,499	0	For
Victory Capital	121,317	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

14. PROPOSAL FIVE - To transact such other business as may properly come before the meeting.

CORPORATE GOVERNANCE

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 5 wordings of this item as funds reported it.

0% fund support · no official result

AGAINST 100%

The 66 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 36,006,903 against).

AGAINST: 36,006,903 (100.0%)

Largest asset managers voting on “PROPOSAL FIVE - To transact such other business as may properly come before the meeting.” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	Against	Vote
BlackRock	9,142,804	Against
State Street	7,441,326	Against
Vanguard	6,611,178	Against
Dimensional	2,092,020	Against
Fidelity	1,951,374	Against
Invesco	1,101,996	Against
T. Rowe Price	813,918	Against
American Century	745,781	Against
Royce	740,385	Against
Direxion Shares ETF Trust	435,872	Against
Northern Trust	368,585	Against
Columbia Threadneedle	356,094	Against
Equitable	269,890	Against
TIAA	259,204	Against
Allspring	256,552	Against
Janus Detroit Street Trust	244,270	Against
Voya	236,211	Against
Goldman Sachs	205,437	Against
BNY Mellon	202,143	Against
AllianceBernstein	186,030	Against
OBERWEIS FUNDS	183,400	Against
Victory Capital	165,407	Against
First Trust	164,343	Against
Brighthouse	155,419	Against
ProShares	147,764	Against

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

15. PROPOSAL FOUR - To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.

AUDIT-RELATED

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 5 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 66 asset managers below cast 100% of the shares they voted on this item FOR (36,006,903 for, 0 against).

FOR: 36,006,903 (100.0%)

Largest asset managers voting on “PROPOSAL FOUR - To ratify the selection of Grant Thornton LLP as our independent registered public accounting ” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
BlackRock	9,142,804	For
State Street	7,441,326	For
Vanguard	6,611,178	For
Dimensional	2,092,020	For
Fidelity	1,951,374	For
Invesco	1,101,996	For
T. Rowe Price	813,918	For
American Century	745,781	For
Royce	740,385	For
Direxion Shares ETF Trust	435,872	For
Northern Trust	368,585	For
Columbia Threadneedle	356,094	For
Equitable	269,890	For
TIAA	259,204	For
Allspring	256,552	For
Janus Detroit Street Trust	244,270	For
Voya	236,211	For
Goldman Sachs	205,437	For
BNY Mellon	202,143	For
AllianceBernstein	186,030	For
OBERWEIS FUNDS	183,400	For
Victory Capital	165,407	For
First Trust	164,343	For
Brighthouse	155,419	For
ProShares	147,764	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

16. PROPOSAL TWO - To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares.

COMPENSATION

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 4 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 66 asset managers below cast 98% of the shares they voted on this item FOR (35,193,312 for, 813,591 against).

FOR: 35,193,312 (97.7%)AGAINST: 813,591 (2.3%)

Largest asset managers voting on “PROPOSAL TWO - To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for i” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	9,142,804	0	For
State Street	7,441,326	0	For
Vanguard	6,611,178	0	For
Dimensional	2,092,020	0	For
Fidelity	1,951,374	0	For
Invesco	1,101,996	0	For
T. Rowe Price	813,918	0	For
American Century	0	745,781	Against
Royce	740,385	0	For
Direxion Shares ETF Trust	435,872	0	For
Northern Trust	368,585	0	For
Columbia Threadneedle	356,094	0	For
Equitable	269,890	0	For
TIAA	259,204	0	For
Allspring	256,552	0	For
Janus Detroit Street Trust	244,270	0	For
Voya	236,211	0	For
Goldman Sachs	205,437	0	For
BNY Mellon	202,143	0	For
AllianceBernstein	186,030	0	For
OBERWEIS FUNDS	183,400	0	For
Victory Capital	165,407	0	For
First Trust	164,343	0	For
Brighthouse	155,419	0	For
ProShares	147,764	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

17. To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 4 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 66 asset managers below cast 99.9% of the shares they voted on this item FOR (35,978,785 for, 28,118 against).

FOR: 35,978,785 (99.9%)AGAINST: 28,118 (0.1%)

Largest asset managers voting on “To elect Charles B. O'Keeffe as a member of the Board of Directors until the 2024 Annual Meeting of Stockholde” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
BlackRock	9,142,804	For
State Street	7,441,326	For
Vanguard	6,611,178	For
Dimensional	2,092,020	For
Fidelity	1,951,374	For
Invesco	1,101,996	For
T. Rowe Price	813,918	For
American Century	745,781	For
Royce	740,385	For
Direxion Shares ETF Trust	435,872	For
Northern Trust	368,585	For
Columbia Threadneedle	356,094	For
Equitable	269,890	For
TIAA	259,204	For
Allspring	256,552	For
Janus Detroit Street Trust	244,270	For
Voya	236,211	For
Goldman Sachs	205,437	For
BNY Mellon	202,143	For
AllianceBernstein	186,030	For
OBERWEIS FUNDS	183,400	For
Victory Capital	165,407	For
First Trust	164,343	For
Brighthouse	155,419	For
ProShares	147,764	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

18. To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

72% fund support · no official result

FOR 72%AGAINST 28%

The 66 asset managers below cast 72% of the shares they voted on this item FOR (26,059,358 for, 9,947,545 against).

FOR: 26,059,358 (72.4%)AGAINST: 9,947,545 (27.6%)

Largest asset managers voting on “To elect David S. Tierney, M.D. as a member of the Board of Directors until the 2024 Annual Meeting of Stockho” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	9,142,804	0	For
State Street	71,307	7,370,019	Against
Vanguard	6,611,178	0	For
Dimensional	0	2,092,020	Against
Fidelity	1,951,374	0	For
Invesco	1,101,996	0	For
T. Rowe Price	813,918	0	For
American Century	745,781	0	For
Royce	740,385	0	For
Direxion Shares ETF Trust	435,872	0	For
Northern Trust	368,585	0	For
Columbia Threadneedle	0	356,094	Against
Equitable	269,890	0	For
TIAA	259,204	0	For
Allspring	256,552	0	For
Janus Detroit Street Trust	244,270	0	For
Voya	236,211	0	For
Goldman Sachs	205,437	0	For
BNY Mellon	202,143	0	For
AllianceBernstein	186,030	0	For
OBERWEIS FUNDS	183,400	0	For
Victory Capital	165,407	0	For
First Trust	164,343	0	For
Brighthouse	155,419	0	For
ProShares	147,764	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

19. To elect Donald A. Denkhaus as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

99.9% fund support · no official result

FOR 99.9%

The 66 asset managers below cast 99.9% of the shares they voted on this item FOR (35,978,785 for, 28,118 against).

FOR: 35,978,785 (99.9%)AGAINST: 28,118 (0.1%)

Largest asset managers voting on “To elect Donald A. Denkhaus as a member of the Board of Directors until the 2024 Annual Meeting of Stockholder” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
BlackRock	9,142,804	For
State Street	7,441,326	For
Vanguard	6,611,178	For
Dimensional	2,092,020	For
Fidelity	1,951,374	For
Invesco	1,101,996	For
T. Rowe Price	813,918	For
American Century	745,781	For
Royce	740,385	For
Direxion Shares ETF Trust	435,872	For
Northern Trust	368,585	For
Columbia Threadneedle	356,094	For
Equitable	269,890	For
TIAA	259,204	For
Allspring	256,552	For
Janus Detroit Street Trust	244,270	For
Voya	236,211	For
Goldman Sachs	205,437	For
BNY Mellon	202,143	For
AllianceBernstein	186,030	For
OBERWEIS FUNDS	183,400	For
Victory Capital	165,407	For
First Trust	164,343	For
Brighthouse	155,419	For
ProShares	147,764	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

20. To elect Molly Harper as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until her earlier death, disability or resignation.

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

99.9% fund support · no official result

FOR 99.9%

The 66 asset managers below cast 99.9% of the shares they voted on this item FOR (35,978,785 for, 28,118 against).

FOR: 35,978,785 (99.9%)AGAINST: 28,118 (0.1%)

Largest asset managers voting on “To elect Molly Harper as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or ” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
BlackRock	9,142,804	For
State Street	7,441,326	For
Vanguard	6,611,178	For
Dimensional	2,092,020	For
Fidelity	1,951,374	For
Invesco	1,101,996	For
T. Rowe Price	813,918	For
American Century	745,781	For
Royce	740,385	For
Direxion Shares ETF Trust	435,872	For
Northern Trust	368,585	For
Columbia Threadneedle	356,094	For
Equitable	269,890	For
TIAA	259,204	For
Allspring	256,552	For
Janus Detroit Street Trust	244,270	For
Voya	236,211	For
Goldman Sachs	205,437	For
BNY Mellon	202,143	For
AllianceBernstein	186,030	For
OBERWEIS FUNDS	183,400	For
Victory Capital	165,407	For
First Trust	164,343	For
Brighthouse	155,419	For
ProShares	147,764	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

21. To elect Patrick J. McEnany as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

99.9% fund support · no official result

FOR 99.9%

The 66 asset managers below cast 99.9% of the shares they voted on this item FOR (35,984,040 for, 22,863 against).

FOR: 35,984,040 (99.9%)AGAINST: 22,863 (0.1%)

Largest asset managers voting on “To elect Patrick J. McEnany as a member of the Board of Directors until the 2024 Annual Meeting of Stockholder” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
BlackRock	9,142,804	For
State Street	7,441,326	For
Vanguard	6,611,178	For
Dimensional	2,092,020	For
Fidelity	1,951,374	For
Invesco	1,101,996	For
T. Rowe Price	813,918	For
American Century	745,781	For
Royce	740,385	For
Direxion Shares ETF Trust	435,872	For
Northern Trust	368,585	For
Columbia Threadneedle	356,094	For
Equitable	269,890	For
TIAA	259,204	For
Allspring	256,552	For
Janus Detroit Street Trust	244,270	For
Voya	236,211	For
Goldman Sachs	205,437	For
BNY Mellon	202,143	For
AllianceBernstein	186,030	For
OBERWEIS FUNDS	183,400	For
Victory Capital	165,407	For
First Trust	164,343	For
Brighthouse	155,419	For
ProShares	147,764	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

22. To elect Richard J. Daly as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until his earlier death, disability or resignation.

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

99.9% fund support · no official result

FOR 99.9%

The 66 asset managers below cast 99.9% of the shares they voted on this item FOR (35,978,785 for, 28,118 against).

FOR: 35,978,785 (99.9%)AGAINST: 28,118 (0.1%)

Largest asset managers voting on “To elect Richard J. Daly as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, ” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
BlackRock	9,142,804	For
State Street	7,441,326	For
Vanguard	6,611,178	For
Dimensional	2,092,020	For
Fidelity	1,951,374	For
Invesco	1,101,996	For
T. Rowe Price	813,918	For
American Century	745,781	For
Royce	740,385	For
Direxion Shares ETF Trust	435,872	For
Northern Trust	368,585	For
Columbia Threadneedle	356,094	For
Equitable	269,890	For
TIAA	259,204	For
Allspring	256,552	For
Janus Detroit Street Trust	244,270	For
Voya	236,211	For
Goldman Sachs	205,437	For
BNY Mellon	202,143	For
AllianceBernstein	186,030	For
OBERWEIS FUNDS	183,400	For
Victory Capital	165,407	For
First Trust	164,343	For
Brighthouse	155,419	For
ProShares	147,764	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

23. To elect Tamar Thompson as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, or until her earlier death, disability or resignation.

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

99.9% fund support · no official result

FOR 99.9%

The 66 asset managers below cast 99.9% of the shares they voted on this item FOR (35,991,643 for, 15,260 against).

FOR: 35,991,643 (100.0%)AGAINST: 15,260 (0.0%)

Largest asset managers voting on “To elect Tamar Thompson as a member of the Board of Directors until the 2024 Annual Meeting of Stockholders, o” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
BlackRock	9,142,804	For
State Street	7,441,326	For
Vanguard	6,611,178	For
Dimensional	2,092,020	For
Fidelity	1,951,374	For
Invesco	1,101,996	For
T. Rowe Price	813,918	For
American Century	745,781	For
Royce	740,385	For
Direxion Shares ETF Trust	435,872	For
Northern Trust	368,585	For
Columbia Threadneedle	356,094	For
Equitable	269,890	For
TIAA	259,204	For
Allspring	256,552	For
Janus Detroit Street Trust	244,270	For
Voya	236,211	For
Goldman Sachs	205,437	For
BNY Mellon	202,143	For
AllianceBernstein	186,030	For
OBERWEIS FUNDS	183,400	For
Victory Capital	165,407	For
First Trust	164,343	For
Brighthouse	155,419	For
ProShares	147,764	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

24. To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares.

COMPENSATIONMajority of the votes cast: yes

Meeting held 2024-05-21.

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 86,817,240AGAINST: 2,859,403

CATALYST PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: Approval of an amendment to our 2018 Stock Incentive Plan:”): 86,817,240 for, 2,859,403 against, per its Form 8-K filed 2024-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 118,029,526 outstanding shares: 74% for, 2% against (76% of the company cast a for/against vote).

The 33 asset managers below cast 99.5% of the shares they voted on this item FOR (3,127,209 for, 14,111 against).

FOR 88%12%

FOR: 3,127,209 (88.0%)AGAINST: 14,111 (0.4%)UNKNOWN: 413,392 (11.6%)

Largest asset managers voting on “To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 mi” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
Charles Schwab	1,016,458	0	For
Altium Capital Management LP	500,000	0	For
JW Asset Management, LLC	0	0	Unknown
JPMorgan	285,125	0	For
Jackson National	243,246	0	For
Russell Investments	117,897	0	For
Prudential/PGIM	115,519	0	For
ADVISORS' INNER CIRCLE FUND	90,000	0	For
RBB FUND, INC.	85,596	0	For
SEI	83,196	0	For
TANAKA FUNDS INC	81,098	0	For
Allianz	66,677	0	For
Catholic Responsible Investments Funds	60,985	0	For
EntrepreneurShares Series Trust	59,577	0	For
Federated Hermes	53,505	0	For
Global X	45,183	0	For
CITY NATIONAL ROCHDALE FUNDS	41,692	0	For
John Hancock	37,569	0	For
Advisors' Inner Circle Fund III	30,211	0	For
PFM Multi-Manager Series Trust	29,227	0	For
Bridge Builder Trust	20,704	0	For
Lincoln Financial	14,769	0	For
Putnam	0	14,111	Against
Tema ETF Trust	11,352	0	For
GPS Funds I	10,217	0	For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

25. Election of Directors Charles B. O'Keeffe

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 4 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.1%

The 30 asset managers below cast 99.9% of the shares they voted on this item FOR (2,776,485 for, 250 against).

FOR: 2,776,485 (99.1%)AGAINST: 250 (0.0%)ABSTAIN: 23,783 (0.8%)

Largest asset managers voting on “Election of Directors Charles B. O'Keeffe” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	858,074	0	For
JPMorgan	330,971	0	For
Jackson National	263,946	0	For
Prudential/PGIM	239,839	0	For
SEI	178,664	0	For
World Funds Trust	154,809	0	For
Russell Investments	123,192	0	For
Federated Hermes	93,445	0	For
Empower	81,227	0	For
ADVISORS' INNER CIRCLE FUND	74,900	0	For
EntrepreneurShares Series Trust	73,805	0	For
Allianz	71,107	0	For
CITY NATIONAL ROCHDALE FUNDS	51,899	0	For
John Hancock	37,701	0	For
RBB FUND, INC.	24,505	0	For
Brighthouse	0	23,783	Abstain
Managed Portfolio Series	22,901	0	For
Lincoln Financial	16,865	0	For
Bridge Builder Trust	16,849	0	For
Putnam	14,779	0	For
NEW COVENANT FUNDS	11,416	0	For
GPS Funds I	10,835	0	For
NORTHERN LIGHTS FUND TRUST II	7,431	0	For
Pacer Funds Trust	5,373	0	For
TIMOTHY PLAN	4,842	0	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

26. Election of Directors David S. Tierney, M.D.

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 3 wordings of this item as funds reported it.

81% fund support · no official result

FOR 80%AGAINST 19%

The 30 asset managers below cast 81% of the shares they voted on this item FOR (2,245,106 for, 531,629 against).

FOR: 2,245,106 (80.2%)AGAINST: 531,629 (19.0%)ABSTAIN: 23,783 (0.8%)

Largest asset managers voting on “Election of Directors David S. Tierney, M.D.” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Charles Schwab	858,074	0	0	For
JPMorgan	330,971	0	0	For
Jackson National	239,217	24,729	0	For
Prudential/PGIM	239,839	0	0	For
SEI	0	178,664	0	Against
World Funds Trust	154,809	0	0	For
Russell Investments	0	123,192	0	Against
Federated Hermes	93,445	0	0	For
Empower	0	81,227	0	Against
ADVISORS' INNER CIRCLE FUND	0	74,900	0	Against
EntrepreneurShares Series Trust	73,805	0	0	For
Allianz	60,057	11,050	0	For
CITY NATIONAL ROCHDALE FUNDS	51,899	0	0	For
John Hancock	37,701	0	0	For
RBB FUND, INC.	24,505	0	0	For
Brighthouse	0	0	23,783	Abstain
Managed Portfolio Series	0	22,901	0	Against
Lincoln Financial	16,865	0	0	For
Bridge Builder Trust	16,849	0	0	For
Putnam	14,779	0	0	For
NEW COVENANT FUNDS	0	11,416	0	Against
GPS Funds I	10,835	0	0	For
NORTHERN LIGHTS FUND TRUST II	7,431	0	0	For
Pacer Funds Trust	5,373	0	0	For
TIMOTHY PLAN	4,842	0	0	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

27. Election of Directors Donald A. Denkhaus

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.1%

The 30 asset managers below cast 100% of the shares they voted on this item FOR (2,776,735 for, 0 against).

FOR: 2,776,735 (99.2%)ABSTAIN: 23,783 (0.8%)

Largest asset managers voting on “Election of Directors Donald A. Denkhaus” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	858,074	0	For
JPMorgan	330,971	0	For
Jackson National	263,946	0	For
Prudential/PGIM	239,839	0	For
SEI	178,664	0	For
World Funds Trust	154,809	0	For
Russell Investments	123,192	0	For
Federated Hermes	93,445	0	For
Empower	81,227	0	For
ADVISORS' INNER CIRCLE FUND	74,900	0	For
EntrepreneurShares Series Trust	73,805	0	For
Allianz	71,107	0	For
CITY NATIONAL ROCHDALE FUNDS	51,899	0	For
John Hancock	37,701	0	For
RBB FUND, INC.	24,505	0	For
Brighthouse	0	23,783	Abstain
Managed Portfolio Series	22,901	0	For
Lincoln Financial	16,865	0	For
Bridge Builder Trust	16,849	0	For
Putnam	14,779	0	For
NEW COVENANT FUNDS	11,416	0	For
GPS Funds I	10,835	0	For
NORTHERN LIGHTS FUND TRUST II	7,431	0	For
Pacer Funds Trust	5,373	0	For
TIMOTHY PLAN	4,842	0	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

28. Election of Directors Molly Harper

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.1%

The 30 asset managers below cast 100% of the shares they voted on this item FOR (2,776,735 for, 0 against).

FOR: 2,776,735 (99.2%)ABSTAIN: 23,783 (0.8%)

Largest asset managers voting on “Election of Directors Molly Harper” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	858,074	0	For
JPMorgan	330,971	0	For
Jackson National	263,946	0	For
Prudential/PGIM	239,839	0	For
SEI	178,664	0	For
World Funds Trust	154,809	0	For
Russell Investments	123,192	0	For
Federated Hermes	93,445	0	For
Empower	81,227	0	For
ADVISORS' INNER CIRCLE FUND	74,900	0	For
EntrepreneurShares Series Trust	73,805	0	For
Allianz	71,107	0	For
CITY NATIONAL ROCHDALE FUNDS	51,899	0	For
John Hancock	37,701	0	For
RBB FUND, INC.	24,505	0	For
Brighthouse	0	23,783	Abstain
Managed Portfolio Series	22,901	0	For
Lincoln Financial	16,865	0	For
Bridge Builder Trust	16,849	0	For
Putnam	14,779	0	For
NEW COVENANT FUNDS	11,416	0	For
GPS Funds I	10,835	0	For
NORTHERN LIGHTS FUND TRUST II	7,431	0	For
Pacer Funds Trust	5,373	0	For
TIMOTHY PLAN	4,842	0	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

29. Election of Directors Patrick J. McEnany

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 5 wordings of this item as funds reported it.

97% fund support · no official result

FOR 96%

The 30 asset managers below cast 97% of the shares they voted on this item FOR (2,695,258 for, 81,477 against).

FOR: 2,695,258 (96.2%)AGAINST: 81,477 (2.9%)ABSTAIN: 23,783 (0.8%)

Largest asset managers voting on “Election of Directors Patrick J. McEnany” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Charles Schwab	858,074	0	0	For
JPMorgan	330,971	0	0	For
Jackson National	263,946	0	0	For
Prudential/PGIM	239,839	0	0	For
SEI	178,664	0	0	For
World Funds Trust	154,809	0	0	For
Russell Investments	123,192	0	0	For
Federated Hermes	93,445	0	0	For
Empower	0	81,227	0	Against
ADVISORS' INNER CIRCLE FUND	74,900	0	0	For
EntrepreneurShares Series Trust	73,805	0	0	For
Allianz	71,107	0	0	For
CITY NATIONAL ROCHDALE FUNDS	51,899	0	0	For
John Hancock	37,701	0	0	For
RBB FUND, INC.	24,505	0	0	For
Brighthouse	0	0	23,783	Abstain
Managed Portfolio Series	22,901	0	0	For
Lincoln Financial	16,865	0	0	For
Bridge Builder Trust	16,849	0	0	For
Putnam	14,779	0	0	For
NEW COVENANT FUNDS	11,416	0	0	For
GPS Funds I	10,835	0	0	For
NORTHERN LIGHTS FUND TRUST II	7,431	0	0	For
Pacer Funds Trust	5,373	0	0	For
TIMOTHY PLAN	4,842	0	0	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

30. Election of Directors Richard J. Daly

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.1%

The 30 asset managers below cast 100% of the shares they voted on this item FOR (2,776,735 for, 0 against).

FOR: 2,776,735 (99.2%)ABSTAIN: 23,783 (0.8%)

Largest asset managers voting on “Election of Directors Richard J. Daly” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	858,074	0	For
JPMorgan	330,971	0	For
Jackson National	263,946	0	For
Prudential/PGIM	239,839	0	For
SEI	178,664	0	For
World Funds Trust	154,809	0	For
Russell Investments	123,192	0	For
Federated Hermes	93,445	0	For
Empower	81,227	0	For
ADVISORS' INNER CIRCLE FUND	74,900	0	For
EntrepreneurShares Series Trust	73,805	0	For
Allianz	71,107	0	For
CITY NATIONAL ROCHDALE FUNDS	51,899	0	For
John Hancock	37,701	0	For
RBB FUND, INC.	24,505	0	For
Brighthouse	0	23,783	Abstain
Managed Portfolio Series	22,901	0	For
Lincoln Financial	16,865	0	For
Bridge Builder Trust	16,849	0	For
Putnam	14,779	0	For
NEW COVENANT FUNDS	11,416	0	For
GPS Funds I	10,835	0	For
NORTHERN LIGHTS FUND TRUST II	7,431	0	For
Pacer Funds Trust	5,373	0	For
TIMOTHY PLAN	4,842	0	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

31. Election of Directors Tamar Thompson

DIRECTOR ELECTIONS

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.1%

The 30 asset managers below cast 100% of the shares they voted on this item FOR (2,776,735 for, 0 against).

FOR: 2,776,735 (99.2%)ABSTAIN: 23,783 (0.8%)

Largest asset managers voting on “Election of Directors Tamar Thompson” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	858,074	0	For
JPMorgan	330,971	0	For
Jackson National	263,946	0	For
Prudential/PGIM	239,839	0	For
SEI	178,664	0	For
World Funds Trust	154,809	0	For
Russell Investments	123,192	0	For
Federated Hermes	93,445	0	For
Empower	81,227	0	For
ADVISORS' INNER CIRCLE FUND	74,900	0	For
EntrepreneurShares Series Trust	73,805	0	For
Allianz	71,107	0	For
CITY NATIONAL ROCHDALE FUNDS	51,899	0	For
John Hancock	37,701	0	For
RBB FUND, INC.	24,505	0	For
Brighthouse	0	23,783	Abstain
Managed Portfolio Series	22,901	0	For
Lincoln Financial	16,865	0	For
Bridge Builder Trust	16,849	0	For
Putnam	14,779	0	For
NEW COVENANT FUNDS	11,416	0	For
GPS Funds I	10,835	0	For
NORTHERN LIGHTS FUND TRUST II	7,431	0	For
Pacer Funds Trust	5,373	0	For
TIMOTHY PLAN	4,842	0	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

32. To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 million shares

COMPENSATION

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

99.4% fund support · no official result

FOR 82%UNKNOWN 17%

The 28 asset managers below cast 99.4% of the shares they voted on this item FOR (2,673,948 for, 14,779 against).

FOR: 2,673,948 (81.6%)AGAINST: 14,779 (0.5%)ABSTAIN: 23,783 (0.7%)UNKNOWN: 563,392 (17.2%)

Largest asset managers voting on “To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 3 mi” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Charles Schwab	858,074	0	0	For
JW Asset Management, LLC	0	0	0	Unknown
JPMorgan	330,971	0	0	For
Jackson National	263,946	0	0	For
Prudential/PGIM	239,839	0	0	For
SEI	178,664	0	0	For
World Funds Trust	154,809	0	0	For
Russell Investments	123,192	0	0	For
Federated Hermes	93,445	0	0	For
ADVISORS' INNER CIRCLE FUND	74,900	0	0	For
EntrepreneurShares Series Trust	73,805	0	0	For
Allianz	71,107	0	0	For
CITY NATIONAL ROCHDALE FUNDS	51,899	0	0	For
John Hancock	37,701	0	0	For
RBB FUND, INC.	24,505	0	0	For
Brighthouse	0	0	23,783	Abstain
Managed Portfolio Series	22,901	0	0	For
Lincoln Financial	16,865	0	0	For
Bridge Builder Trust	16,849	0	0	For
Putnam	0	14,779	0	Against
NEW COVENANT FUNDS	11,416	0	0	For
GPS Funds I	10,835	0	0	For
NORTHERN LIGHTS FUND TRUST II	7,431	0	0	For
Pacer Funds Trust	5,373	0	0	For
WILSHIRE MUTUAL FUNDS INC	3,300	0	0	For

Showing the 25 largest of 28 asset managers. See all 28 in the interactive database.

33. To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023

AUDIT-RELATED

Meeting held 2023-08-22; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.1%

The 27 asset managers below cast 100% of the shares they voted on this item FOR (2,688,727 for, 0 against).

FOR: 2,688,727 (99.1%)ABSTAIN: 23,783 (0.9%)

Largest asset managers voting on “To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fis” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	858,074	0	For
JPMorgan	330,971	0	For
Jackson National	263,946	0	For
Prudential/PGIM	239,839	0	For
SEI	178,664	0	For
World Funds Trust	154,809	0	For
Russell Investments	123,192	0	For
Federated Hermes	93,445	0	For
ADVISORS' INNER CIRCLE FUND	74,900	0	For
EntrepreneurShares Series Trust	73,805	0	For
Allianz	71,107	0	For
CITY NATIONAL ROCHDALE FUNDS	51,899	0	For
John Hancock	37,701	0	For
RBB FUND, INC.	24,505	0	For
Brighthouse	0	23,783	Abstain
Managed Portfolio Series	22,901	0	For
Lincoln Financial	16,865	0	For
Bridge Builder Trust	16,849	0	For
Putnam	14,779	0	For
NEW COVENANT FUNDS	11,416	0	For
GPS Funds I	10,835	0	For
NORTHERN LIGHTS FUND TRUST II	7,431	0	For
Pacer Funds Trust	5,373	0	For
WILSHIRE MUTUAL FUNDS INC	3,300	0	For
SYNTAX ETF TRUST	1,762	0	For

Showing the 25 largest of 27 asset managers. See all 27 in the interactive database.

34. TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING.

OTHER

Meeting held 2023-08-22; no official results are on file for this meeting.

13% fund support · no official result

13%AGAINST 86%

The 27 asset managers below cast 13% of the shares they voted on this item FOR (348,195 for, 2,340,532 against).

FOR: 348,195 (12.8%)AGAINST: 2,340,532 (86.3%)ABSTAIN: 23,783 (0.9%)

Largest asset managers voting on “TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING.” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Charles Schwab	0	858,074	0	Against
JPMorgan	330,971	0	0	For
Jackson National	0	263,946	0	Against
Prudential/PGIM	0	239,839	0	Against
SEI	0	178,664	0	Against
World Funds Trust	0	154,809	0	Against
Russell Investments	0	123,192	0	Against
Federated Hermes	0	93,445	0	Against
ADVISORS' INNER CIRCLE FUND	0	74,900	0	Against
EntrepreneurShares Series Trust	0	73,805	0	Against
Allianz	0	71,107	0	Against
CITY NATIONAL ROCHDALE FUNDS	0	51,899	0	Against
John Hancock	0	37,701	0	Against
RBB FUND, INC.	0	24,505	0	Against
Brighthouse	0	0	23,783	Abstain
Managed Portfolio Series	0	22,901	0	Against
Lincoln Financial	16,865	0	0	For
Bridge Builder Trust	0	16,849	0	Against
Putnam	0	14,779	0	Against
NEW COVENANT FUNDS	0	11,416	0	Against
GPS Funds I	0	10,835	0	Against
NORTHERN LIGHTS FUND TRUST II	0	7,431	0	Against
Pacer Funds Trust	0	5,373	0	Against
WILSHIRE MUTUAL FUNDS INC	0	3,300	0	Against
SYNTAX ETF TRUST	0	1,762	0	Against

Showing the 25 largest of 27 asset managers. See all 27 in the interactive database.

35. ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2023-08-22; no official results are on file for this meeting.

93% fund support · no official result

FOR 93%

The 7 asset managers below cast 93% of the shares they voted on this item FOR (428,329 for, 31,984 against).

FOR: 428,329 (93.1%)AGAINST: 31,984 (6.9%)

Largest asset managers voting on “ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Vote
JPMorgan	340,057	0	For
Empower	81,227	0	For
MILLER HOWARD INVESTMENTS INC /NY	0	31,984	Against
TIMOTHY PLAN	4,842	0	For
CORNELL UNIVERSITY	1,939	0	For
Convergence Investment Partners, LLC	249	0	For
TD ASSET MANAGEMENT INC	15	0	For

36. AMEND OMNIBUS STOCK PLAN

COMPENSATION

Meeting held 2023-08-22; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (88,008 for, 0 against).

FOR: 88,008 (100.0%)

Largest asset managers voting on “AMEND OMNIBUS STOCK PLAN” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Empower	81,227	For
TIMOTHY PLAN	4,842	For
CORNELL UNIVERSITY	1,939	For

37. RATIFY GRANT THORNTON LLP AS AUDITORS

AUDIT-RELATED

Meeting held 2023-08-22; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (88,008 for, 0 against).

FOR: 88,008 (100.0%)

Largest asset managers voting on “RATIFY GRANT THORNTON LLP AS AUDITORS” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Vote
Empower	81,227	For
TIMOTHY PLAN	4,842	For
CORNELL UNIVERSITY	1,939	For

38. AMEND OMNIBUS STOCK PLAN

COMPENSATION

Meeting held 2024-05-21.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (96,910 for, 0 against).

FOR: 96,910 (100.0%)

Largest asset managers voting on “AMEND OMNIBUS STOCK PLAN” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Empower	86,986	0	0	0	For
TIMOTHY PLAN	9,924	0	0	0	For

39. ELECT DIRECTOR DAVID S. TIERNEY

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-05-21.

96% Majority: yes · of votes cast

FOR 96%

FOR: 85,767,244AGAINST: 3,885,606

The 2 asset managers below cast 10% of the shares they voted on this item FOR (9,924 for, 86,986 against).

10%AGAINST 90%

FOR: 9,924 (10.2%)AGAINST: 86,986 (89.8%)

Largest asset managers voting on “ELECT DIRECTOR DAVID S. TIERNEY” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Empower	0	86,986	0	0	Against
TIMOTHY PLAN	9,924	0	0	0	For

40. OTHER BUSINESS

OTHER

Meeting held 2024-05-21.

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 96,910 against).

AGAINST: 96,910 (100.0%)

Largest asset managers voting on “OTHER BUSINESS” at CATALYST PHARMACEUTICALS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Empower	0	86,986	0	0	Against
TIMOTHY PLAN	0	9,924	0	0	Against

Showing the 40 reported items with the widest manager coverage, of 43 in total. View every item.

Largest CATALYST PHARMACEUTICALS INC. shareholders voting in 2023-2024

Ranked by the number of CATALYST PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 118,029,526 shares outstanding at the time of that meeting.

Top CATALYST PHARMACEUTICALS INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	BlackRock	13.41%
2	State Street	11.73%
3	Vanguard	6.76%
4	DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	3.43%
5	Fidelity	2.27%
6	Dimensional	2.19%
7	GEODE CAPITAL MANAGEMENT, LLC	2.12%
8	Man Group plc	2.11%
9	T. Rowe Price	1.79%
10	Charles Schwab	1.77%

Reported CATALYST PHARMACEUTICALS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CATALYST PHARMACEUTICALS INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	15.43%	13F
Vanguard Group	7.38%	13F
State Street	6.91%	13F
S	5.28%	13G
Dimensional Fund Advisors	2.32%	13F
Geode Capital	2.13%	13F
Renaissance Technologies	1.60%	13F
Morgan Stanley	1.56%	13F
Northern Trust	1.21%	13F
T. Rowe Price	1.03%	13F

Percentages above are of 118,029,526 shares outstanding, as reported by CATALYST PHARMACEUTICALS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CATALYST PHARMACEUTICALS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At CATALYST PHARMACEUTICALS INC.'s 2 shareholder meetings in the 2023-2024 proxy season (held 2023-08-22 and 2024-05-21), 333 asset managers reported how they voted in their SEC Form N-PX filings, covering 7,406 separate fund positions. Their filings are grouped here into 43 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2024-05-21 — To approve, on an advisory basis, the 2023 compensation of our named executive officers. — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CATALYST PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-21.

CATALYST PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.